nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—HTR2A—Alzheimer's disease	0.266	1	CbGaD
Ergotamine—HTR2A—Donepezil—Alzheimer's disease	0.181	0.415	CbGbCtD
Ergotamine—DRD2—Memantine—Alzheimer's disease	0.144	0.331	CbGbCtD
Ergotamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0478	0.11	CbGbCtD
Ergotamine—CYP3A4—Donepezil—Alzheimer's disease	0.0382	0.0877	CbGbCtD
Ergotamine—CYP3A4—Galantamine—Alzheimer's disease	0.0246	0.0565	CbGbCtD
Ergotamine—HTR2C—choroid plexus—Alzheimer's disease	0.0135	0.114	CbGeAlD
Ergotamine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00694	0.0589	CbGeAlD
Ergotamine—HTR2A—choroid plexus—Alzheimer's disease	0.00675	0.0573	CbGeAlD
Ergotamine—HTR2A—locus ceruleus—Alzheimer's disease	0.00417	0.0354	CbGeAlD
Ergotamine—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00411	0.0349	CbGeAlD
Ergotamine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00398	0.0338	CbGeAlD
Ergotamine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00394	0.0335	CbGeAlD
Ergotamine—HTR2A—cerebellar cortex—Alzheimer's disease	0.0034	0.0289	CbGeAlD
Ergotamine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00332	0.0282	CbGeAlD
Ergotamine—DRD2—telencephalic ventricle—Alzheimer's disease	0.003	0.0255	CbGeAlD
Ergotamine—Numbness—Donepezil—Alzheimer's disease	0.00278	0.0581	CcSEcCtD
Ergotamine—Sensory loss—Donepezil—Alzheimer's disease	0.00266	0.0556	CcSEcCtD
Ergotamine—HTR1F—forebrain—Alzheimer's disease	0.00262	0.0222	CbGeAlD
Ergotamine—Numbness—Memantine—Alzheimer's disease	0.00253	0.0527	CcSEcCtD
Ergotamine—Sensory loss—Memantine—Alzheimer's disease	0.00242	0.0505	CcSEcCtD
Ergotamine—HTR1F—telencephalon—Alzheimer's disease	0.00241	0.0205	CbGeAlD
Ergotamine—HTR1E—forebrain—Alzheimer's disease	0.00227	0.0193	CbGeAlD
Ergotamine—HTR1E—telencephalon—Alzheimer's disease	0.00209	0.0177	CbGeAlD
Ergotamine—HTR1B—blood vessel—Alzheimer's disease	0.00204	0.0173	CbGeAlD
Ergotamine—Dihydroergotamine—HTR6—Alzheimer's disease	0.00202	0.329	CrCbGaD
Ergotamine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00198	0.0168	CbGeAlD
Ergotamine—HTR1D—blood vessel—Alzheimer's disease	0.00197	0.0167	CbGeAlD
Ergotamine—Bradycardia—Galantamine—Alzheimer's disease	0.00152	0.0318	CcSEcCtD
Ergotamine—HTR1F—nervous system—Alzheimer's disease	0.00142	0.0121	CbGeAlD
Ergotamine—ADRA1D—forebrain—Alzheimer's disease	0.00139	0.0118	CbGeAlD
Ergotamine—HTR1F—central nervous system—Alzheimer's disease	0.00137	0.0116	CbGeAlD
Ergotamine—Methysergide—HTR6—Alzheimer's disease	0.00135	0.219	CrCbGaD
Ergotamine—ADRA1D—telencephalon—Alzheimer's disease	0.00128	0.0109	CbGeAlD
Ergotamine—HTR1E—nervous system—Alzheimer's disease	0.00123	0.0105	CbGeAlD
Ergotamine—HTR1E—central nervous system—Alzheimer's disease	0.00119	0.0101	CbGeAlD
Ergotamine—Bradycardia—Donepezil—Alzheimer's disease	0.00118	0.0246	CcSEcCtD
Ergotamine—Vertigo—Galantamine—Alzheimer's disease	0.00117	0.0244	CcSEcCtD
Ergotamine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00115	0.0241	CcSEcCtD
Ergotamine—Hypertension—Galantamine—Alzheimer's disease	0.00112	0.0234	CcSEcCtD
Ergotamine—Myalgia—Galantamine—Alzheimer's disease	0.00111	0.0231	CcSEcCtD
Ergotamine—HTR1F—brain—Alzheimer's disease	0.00109	0.00923	CbGeAlD
Ergotamine—HTR1B—forebrain—Alzheimer's disease	0.00107	0.00912	CbGeAlD
Ergotamine—Bradycardia—Memantine—Alzheimer's disease	0.00107	0.0223	CcSEcCtD
Ergotamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00105	0.0219	CcSEcCtD
Ergotamine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00105	0.0218	CcSEcCtD
Ergotamine—HTR1D—forebrain—Alzheimer's disease	0.00104	0.00883	CbGeAlD
Ergotamine—Tachycardia—Galantamine—Alzheimer's disease	0.00104	0.0216	CcSEcCtD
Ergotamine—HTR2C—forebrain—Alzheimer's disease	0.00103	0.00874	CbGeAlD
Ergotamine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00102	0.0214	CcSEcCtD
Ergotamine—Bromocriptine—HTR6—Alzheimer's disease	0.001	0.163	CrCbGaD
Ergotamine—HTR1B—telencephalon—Alzheimer's disease	0.000988	0.00838	CbGeAlD
Ergotamine—HTR2A—blood vessel—Alzheimer's disease	0.000979	0.00831	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000968	0.0202	CcSEcCtD
Ergotamine—HTR2B—forebrain—Alzheimer's disease	0.000968	0.00821	CbGeAlD
Ergotamine—HTR1D—telencephalon—Alzheimer's disease	0.000956	0.00812	CbGeAlD
Ergotamine—Paraesthesia—Galantamine—Alzheimer's disease	0.000954	0.0199	CcSEcCtD
Ergotamine—HTR2C—telencephalon—Alzheimer's disease	0.000947	0.00804	CbGeAlD
Ergotamine—HTR1E—brain—Alzheimer's disease	0.000942	0.008	CbGeAlD
Ergotamine—Vertigo—Donepezil—Alzheimer's disease	0.000906	0.0189	CcSEcCtD
Ergotamine—HTR2B—telencephalon—Alzheimer's disease	0.00089	0.00755	CbGeAlD
Ergotamine—Hypertension—Donepezil—Alzheimer's disease	0.000871	0.0182	CcSEcCtD
Ergotamine—HTR1A—forebrain—Alzheimer's disease	0.000867	0.00736	CbGeAlD
Ergotamine—SLC6A2—forebrain—Alzheimer's disease	0.00086	0.00729	CbGeAlD
Ergotamine—Myalgia—Donepezil—Alzheimer's disease	0.000859	0.0179	CcSEcCtD
Ergotamine—Vertigo—Memantine—Alzheimer's disease	0.000823	0.0172	CcSEcCtD
Ergotamine—Vertigo—Rivastigmine—Alzheimer's disease	0.000805	0.0168	CcSEcCtD
Ergotamine—ADRA1A—forebrain—Alzheimer's disease	0.000799	0.00678	CbGeAlD
Ergotamine—HTR1A—telencephalon—Alzheimer's disease	0.000797	0.00676	CbGeAlD
Ergotamine—Hypertension—Memantine—Alzheimer's disease	0.000791	0.0165	CcSEcCtD
Ergotamine—SLC6A2—telencephalon—Alzheimer's disease	0.00079	0.00671	CbGeAlD
Ergotamine—DRD2—forebrain—Alzheimer's disease	0.000783	0.00665	CbGeAlD
Ergotamine—Myalgia—Memantine—Alzheimer's disease	0.00078	0.0163	CcSEcCtD
Ergotamine—Hypertension—Rivastigmine—Alzheimer's disease	0.000773	0.0161	CcSEcCtD
Ergotamine—ADRA1B—nervous system—Alzheimer's disease	0.000772	0.00655	CbGeAlD
Ergotamine—Myalgia—Rivastigmine—Alzheimer's disease	0.000763	0.0159	CcSEcCtD
Ergotamine—Asthenia—Galantamine—Alzheimer's disease	0.000762	0.0159	CcSEcCtD
Ergotamine—ADRA1D—nervous system—Alzheimer's disease	0.000755	0.00641	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00075	0.0157	CcSEcCtD
Ergotamine—ADRA1B—central nervous system—Alzheimer's disease	0.000743	0.00631	CbGeAlD
Ergotamine—Paraesthesia—Donepezil—Alzheimer's disease	0.000739	0.0154	CcSEcCtD
Ergotamine—ADRA1A—telencephalon—Alzheimer's disease	0.000735	0.00624	CbGeAlD
Ergotamine—Tachycardia—Memantine—Alzheimer's disease	0.000729	0.0152	CcSEcCtD
Ergotamine—ADRA1D—central nervous system—Alzheimer's disease	0.000727	0.00617	CbGeAlD
Ergotamine—DRD2—telencephalon—Alzheimer's disease	0.00072	0.00611	CbGeAlD
Ergotamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000713	0.0149	CcSEcCtD
Ergotamine—Pain—Donepezil—Alzheimer's disease	0.000704	0.0147	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000681	0.0142	CcSEcCtD
Ergotamine—Vomiting—Galantamine—Alzheimer's disease	0.000675	0.0141	CcSEcCtD
Ergotamine—Paraesthesia—Memantine—Alzheimer's disease	0.000671	0.014	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000666	0.0139	CcSEcCtD
Ergotamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000656	0.0137	CcSEcCtD
Ergotamine—ABCB1—blood vessel—Alzheimer's disease	0.000642	0.00545	CbGeAlD
Ergotamine—Pain—Memantine—Alzheimer's disease	0.000639	0.0133	CcSEcCtD
Ergotamine—Nausea—Galantamine—Alzheimer's disease	0.000631	0.0132	CcSEcCtD
Ergotamine—Pain—Rivastigmine—Alzheimer's disease	0.000625	0.013	CcSEcCtD
Ergotamine—ADRA2A—forebrain—Alzheimer's disease	0.000608	0.00516	CbGeAlD
Ergotamine—Asthenia—Donepezil—Alzheimer's disease	0.00059	0.0123	CcSEcCtD
Ergotamine—ADRA1B—brain—Alzheimer's disease	0.00059	0.00501	CbGeAlD
Ergotamine—HTR2A—embryo—Alzheimer's disease	0.000584	0.00496	CbGeAlD
Ergotamine—HTR1B—nervous system—Alzheimer's disease	0.000583	0.00495	CbGeAlD
Ergotamine—Pruritus—Donepezil—Alzheimer's disease	0.000582	0.0122	CcSEcCtD
Ergotamine—ADRA1D—brain—Alzheimer's disease	0.000577	0.0049	CbGeAlD
Ergotamine—HTR1D—nervous system—Alzheimer's disease	0.000565	0.00479	CbGeAlD
Ergotamine—HTR1B—central nervous system—Alzheimer's disease	0.000561	0.00476	CbGeAlD
Ergotamine—HTR2C—nervous system—Alzheimer's disease	0.000559	0.00474	CbGeAlD
Ergotamine—ADRA2A—telencephalon—Alzheimer's disease	0.000559	0.00474	CbGeAlD
Ergotamine—HTR1D—central nervous system—Alzheimer's disease	0.000544	0.00461	CbGeAlD
Ergotamine—HTR2C—central nervous system—Alzheimer's disease	0.000538	0.00457	CbGeAlD
Ergotamine—Asthenia—Memantine—Alzheimer's disease	0.000536	0.0112	CcSEcCtD
Ergotamine—Pruritus—Memantine—Alzheimer's disease	0.000529	0.011	CcSEcCtD
Ergotamine—HTR2B—nervous system—Alzheimer's disease	0.000525	0.00446	CbGeAlD
Ergotamine—Asthenia—Rivastigmine—Alzheimer's disease	0.000525	0.0109	CcSEcCtD
Ergotamine—Vomiting—Donepezil—Alzheimer's disease	0.000523	0.0109	CcSEcCtD
Ergotamine—Pruritus—Rivastigmine—Alzheimer's disease	0.000517	0.0108	CcSEcCtD
Ergotamine—HTR2A—forebrain—Alzheimer's disease	0.000517	0.00438	CbGeAlD
Ergotamine—HTR2B—central nervous system—Alzheimer's disease	0.000506	0.00429	CbGeAlD
Ergotamine—Nausea—Donepezil—Alzheimer's disease	0.000489	0.0102	CcSEcCtD
Ergotamine—Methylergometrine—HTR2A—Alzheimer's disease	0.000476	0.0773	CrCbGaD
Ergotamine—Vomiting—Memantine—Alzheimer's disease	0.000475	0.00992	CcSEcCtD
Ergotamine—HTR2A—telencephalon—Alzheimer's disease	0.000475	0.00403	CbGeAlD
Ergotamine—HTR1A—nervous system—Alzheimer's disease	0.000471	0.00399	CbGeAlD
Ergotamine—SLC6A2—nervous system—Alzheimer's disease	0.000467	0.00396	CbGeAlD
Ergotamine—Vomiting—Rivastigmine—Alzheimer's disease	0.000465	0.0097	CcSEcCtD
Ergotamine—HTR1A—central nervous system—Alzheimer's disease	0.000453	0.00384	CbGeAlD
Ergotamine—SLC6A2—central nervous system—Alzheimer's disease	0.000449	0.00381	CbGeAlD
Ergotamine—HTR1B—brain—Alzheimer's disease	0.000446	0.00378	CbGeAlD
Ergotamine—Nausea—Memantine—Alzheimer's disease	0.000444	0.00926	CcSEcCtD
Ergotamine—HTR1A—cerebellum—Alzheimer's disease	0.000443	0.00376	CbGeAlD
Ergotamine—Nausea—Rivastigmine—Alzheimer's disease	0.000434	0.00906	CcSEcCtD
Ergotamine—ADRA1A—nervous system—Alzheimer's disease	0.000434	0.00368	CbGeAlD
Ergotamine—HTR1D—brain—Alzheimer's disease	0.000432	0.00366	CbGeAlD
Ergotamine—HTR2C—brain—Alzheimer's disease	0.000427	0.00363	CbGeAlD
Ergotamine—DRD2—nervous system—Alzheimer's disease	0.000425	0.00361	CbGeAlD
Ergotamine—ADRA1A—central nervous system—Alzheimer's disease	0.000418	0.00354	CbGeAlD
Ergotamine—DRD2—central nervous system—Alzheimer's disease	0.000409	0.00347	CbGeAlD
Ergotamine—ADRA1A—cerebellum—Alzheimer's disease	0.000408	0.00346	CbGeAlD
Ergotamine—HTR2B—brain—Alzheimer's disease	0.000401	0.00341	CbGeAlD
Ergotamine—DRD2—cerebellum—Alzheimer's disease	0.0004	0.0034	CbGeAlD
Ergotamine—Methysergide—HTR2A—Alzheimer's disease	0.000397	0.0645	CrCbGaD
Ergotamine—ABCB1—embryo—Alzheimer's disease	0.000383	0.00325	CbGeAlD
Ergotamine—HTR1A—brain—Alzheimer's disease	0.00036	0.00305	CbGeAlD
Ergotamine—SLC6A2—brain—Alzheimer's disease	0.000357	0.00303	CbGeAlD
Ergotamine—ABCB1—forebrain—Alzheimer's disease	0.000339	0.00287	CbGeAlD
Ergotamine—ADRA1A—brain—Alzheimer's disease	0.000332	0.00281	CbGeAlD
Ergotamine—ADRA2A—nervous system—Alzheimer's disease	0.00033	0.0028	CbGeAlD
Ergotamine—DRD2—brain—Alzheimer's disease	0.000325	0.00276	CbGeAlD
Ergotamine—Lisuride—HTR2A—Alzheimer's disease	0.000319	0.0518	CrCbGaD
Ergotamine—ADRA2A—central nervous system—Alzheimer's disease	0.000318	0.00269	CbGeAlD
Ergotamine—ABCB1—telencephalon—Alzheimer's disease	0.000311	0.00264	CbGeAlD
Ergotamine—ADRA2A—cerebellum—Alzheimer's disease	0.00031	0.00263	CbGeAlD
Ergotamine—Bromocriptine—HTR2A—Alzheimer's disease	0.000296	0.048	CrCbGaD
Ergotamine—Lisuride—CYP2D6—Alzheimer's disease	0.000292	0.0474	CrCbGaD
Ergotamine—HTR2A—nervous system—Alzheimer's disease	0.00028	0.00238	CbGeAlD
Ergotamine—HTR2A—central nervous system—Alzheimer's disease	0.00027	0.00229	CbGeAlD
Ergotamine—HTR2A—cerebellum—Alzheimer's disease	0.000264	0.00224	CbGeAlD
Ergotamine—CYP3A4—nervous system—Alzheimer's disease	0.00026	0.0022	CbGeAlD
Ergotamine—ADRA2A—brain—Alzheimer's disease	0.000252	0.00214	CbGeAlD
Ergotamine—CYP3A4—central nervous system—Alzheimer's disease	0.00025	0.00212	CbGeAlD
Ergotamine—HTR2A—brain—Alzheimer's disease	0.000214	0.00182	CbGeAlD
Ergotamine—ABCB1—nervous system—Alzheimer's disease	0.000184	0.00156	CbGeAlD
Ergotamine—ABCB1—central nervous system—Alzheimer's disease	0.000177	0.0015	CbGeAlD
Ergotamine—ABCB1—cerebellum—Alzheimer's disease	0.000173	0.00147	CbGeAlD
Ergotamine—ABCB1—brain—Alzheimer's disease	0.00014	0.00119	CbGeAlD
Ergotamine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	6.08e-06	4.83e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	6.06e-06	4.82e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	6.06e-06	4.82e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	6.06e-06	4.82e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.05e-06	4.81e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	6.04e-06	4.81e-05	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.04e-06	4.8e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	6.03e-06	4.8e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	6.03e-06	4.79e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	6e-06	4.78e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	6e-06	4.78e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—Alzheimer's disease	6e-06	4.77e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	6e-06	4.77e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	5.99e-06	4.77e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	5.98e-06	4.76e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.97e-06	4.75e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	5.96e-06	4.74e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	5.95e-06	4.74e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.95e-06	4.73e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	5.94e-06	4.73e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	5.93e-06	4.72e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	5.93e-06	4.72e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	5.93e-06	4.72e-05	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.91e-06	4.7e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	5.9e-06	4.69e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	5.88e-06	4.68e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	5.88e-06	4.68e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	5.87e-06	4.67e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	5.86e-06	4.66e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	5.82e-06	4.63e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—F2—Alzheimer's disease	5.81e-06	4.62e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	5.8e-06	4.61e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	5.79e-06	4.6e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	5.79e-06	4.6e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	5.77e-06	4.59e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	5.74e-06	4.57e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	5.74e-06	4.57e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	5.71e-06	4.55e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.71e-06	4.54e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	5.71e-06	4.54e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	5.68e-06	4.52e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	5.67e-06	4.51e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—Alzheimer's disease	5.66e-06	4.5e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—INS—Alzheimer's disease	5.63e-06	4.48e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	5.62e-06	4.47e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	5.6e-06	4.46e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.6e-06	4.45e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	5.6e-06	4.45e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.59e-06	4.45e-05	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.55e-06	4.42e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.53e-06	4.4e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	5.53e-06	4.4e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	5.52e-06	4.39e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	5.51e-06	4.39e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	5.51e-06	4.39e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	5.5e-06	4.38e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	5.5e-06	4.37e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—Alzheimer's disease	5.49e-06	4.37e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	5.48e-06	4.36e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.48e-06	4.36e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	5.47e-06	4.35e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	5.46e-06	4.35e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	5.44e-06	4.33e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—LPL—Alzheimer's disease	5.44e-06	4.33e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	5.38e-06	4.28e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	5.37e-06	4.27e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.36e-06	4.26e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	5.33e-06	4.24e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.3e-06	4.21e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	5.29e-06	4.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.26e-06	4.19e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—INS—Alzheimer's disease	5.26e-06	4.19e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	5.26e-06	4.18e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.25e-06	4.18e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	5.23e-06	4.16e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	5.21e-06	4.14e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	5.2e-06	4.14e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—Alzheimer's disease	5.18e-06	4.12e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	5.18e-06	4.12e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	5.18e-06	4.12e-05	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	5.17e-06	4.11e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	5.14e-06	4.09e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	5.12e-06	4.07e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	5.1e-06	4.06e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	5.09e-06	4.05e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	5.09e-06	4.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.09e-06	4.05e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	5.09e-06	4.05e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	5.08e-06	4.04e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	5.07e-06	4.03e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—AKT1—Alzheimer's disease	5.06e-06	4.03e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	5.06e-06	4.02e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	5.04e-06	4.01e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.02e-06	4e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.02e-06	4e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	5.01e-06	3.98e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	5e-06	3.98e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	4.99e-06	3.97e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	4.97e-06	3.95e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	4.94e-06	3.93e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.93e-06	3.92e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	4.9e-06	3.9e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.9e-06	3.9e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	4.78e-06	3.8e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	4.77e-06	3.8e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.77e-06	3.79e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.75e-06	3.78e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	4.74e-06	3.77e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	4.71e-06	3.75e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	4.71e-06	3.74e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	4.69e-06	3.73e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.67e-06	3.71e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	4.67e-06	3.71e-05	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.66e-06	3.71e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	4.66e-06	3.71e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	4.63e-06	3.69e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	4.62e-06	3.68e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	4.61e-06	3.67e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	4.59e-06	3.65e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.58e-06	3.64e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	4.56e-06	3.63e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—APOE—Alzheimer's disease	4.56e-06	3.63e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.56e-06	3.62e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	4.54e-06	3.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	4.52e-06	3.59e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.52e-06	3.59e-05	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.5e-06	3.58e-05	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	4.48e-06	3.56e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	4.46e-06	3.55e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	4.45e-06	3.54e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	4.44e-06	3.53e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	4.43e-06	3.53e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	4.41e-06	3.51e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.41e-06	3.51e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	4.34e-06	3.46e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.34e-06	3.45e-05	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.29e-06	3.41e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	4.29e-06	3.41e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.27e-06	3.4e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	4.25e-06	3.38e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	4.25e-06	3.38e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	4.24e-06	3.37e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	4.22e-06	3.36e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.13e-06	3.29e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	4.1e-06	3.26e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	4.09e-06	3.25e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	4.08e-06	3.25e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	4.07e-06	3.24e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	3.99e-06	3.17e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.97e-06	3.16e-05	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.95e-06	3.15e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.92e-06	3.12e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	3.92e-06	3.12e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.91e-06	3.11e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.91e-06	3.11e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—INS—Alzheimer's disease	3.9e-06	3.1e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.89e-06	3.1e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	3.89e-06	3.1e-05	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.89e-06	3.09e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	3.85e-06	3.07e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	3.84e-06	3.05e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	3.83e-06	3.05e-05	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.81e-06	3.03e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.79e-06	3.01e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	3.77e-06	3e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	3.77e-06	3e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	3.76e-06	2.99e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	3.75e-06	2.98e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.68e-06	2.93e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.66e-06	2.91e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.65e-06	2.91e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.64e-06	2.9e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.61e-06	2.87e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	3.61e-06	2.87e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	3.6e-06	2.86e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	3.6e-06	2.86e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	3.59e-06	2.86e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.54e-06	2.82e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.54e-06	2.82e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.53e-06	2.81e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	3.53e-06	2.81e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	3.51e-06	2.79e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.51e-06	2.79e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.48e-06	2.77e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.48e-06	2.76e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	3.47e-06	2.76e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	3.46e-06	2.75e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	3.46e-06	2.75e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	3.44e-06	2.73e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.42e-06	2.72e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.35e-06	2.67e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.32e-06	2.64e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	3.31e-06	2.63e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	3.28e-06	2.61e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.27e-06	2.6e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	3.24e-06	2.58e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	3.23e-06	2.57e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.22e-06	2.56e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.21e-06	2.56e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.2e-06	2.55e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	3.17e-06	2.52e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.17e-06	2.52e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.12e-06	2.49e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—INS—Alzheimer's disease	3.11e-06	2.47e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	3.05e-06	2.43e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.02e-06	2.4e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	3e-06	2.39e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	3e-06	2.39e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	2.98e-06	2.37e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.98e-06	2.37e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	2.96e-06	2.36e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.94e-06	2.34e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	2.86e-06	2.28e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.85e-06	2.26e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.82e-06	2.24e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.81e-06	2.23e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.78e-06	2.21e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.77e-06	2.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.73e-06	2.17e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.73e-06	2.17e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.72e-06	2.17e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	2.71e-06	2.16e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	2.62e-06	2.08e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	2.61e-06	2.07e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.51e-06	2e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	2.5e-06	1.99e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.49e-06	1.98e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	2.49e-06	1.98e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	2.47e-06	1.97e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.45e-06	1.95e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2.42e-06	1.93e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	2.42e-06	1.92e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	2.4e-06	1.91e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.4e-06	1.91e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	2.3e-06	1.83e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.3e-06	1.83e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	2.27e-06	1.81e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	2.26e-06	1.8e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	2.25e-06	1.79e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.22e-06	1.76e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.12e-06	1.69e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.1e-06	1.67e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	2.09e-06	1.66e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	2.06e-06	1.64e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	2.04e-06	1.63e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.92e-06	1.53e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.9e-06	1.51e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.57e-06	1.25e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.25e-06	9.97e-06	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.67e-07	7.7e-06	CbGpPWpGaD
